Protara Therapeutic Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.98

-0.09 (-2.21%)

As of Jun 21, 10:26 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +488.9% upside

Low Target $15.10

Average Target $23.44

High Target $28.04

Current Price $3.98

Current
$3.98

Target
$23.44

$15.10 $23.44 avg $28.04

Scenario Analysis

Bear Case

$15.10

279.4%

Low target

Base Case

$23.44

+488.9%

Avg target

Bull Case

$28.04

+604.5%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$7.82

-49.1% from high

52-Week Low

$2.77

+43.7% from low

Target vs 52W High

$23.44

+199.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.7%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+189.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-7.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.0%